Wrong statement about digoxin in heart failure:
a) No mortality benefit
b) Reduces symptoms
c) Reduces recurrent hospitalizations
d) Class I recommendation
Wrong statement about anthracycline cardiotoxicity:
a) Long term anthracycline cardiotoxicity is type II
b) More in elderly
c) Cyclophosphamide increases risk
d) Total cumulative dose is important
Type III cardiorenal syndrome is:
a) Acute cardiorenal syndrome
b) Acute renocardiac syndrome
c) Chronic cardiorenal syndrome
d) Chronic renocardiac syndrome